Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Helman

Showing results (141-150 of 211) with videos related to

Pageof 22
Sort By:
Methods in Enzymology|January 1, 1990
Dispersed salivary gland acinar cell preparations for use in studies of neuroreceptor-coupled secretory eventsB J Baum, I S Ambudkar, J Helman, et al.
Neoplasia (New York, N.Y.)|May 29, 2020
Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomasEmad Darvishi, Katherine Slemmons, Zesheng Wan, et al.
The Journal of Biological Chemistry|May 1, 1999
Diminished G1 checkpoint after gamma-irradiation and altered cell cycle regulation by insulin-like growth factor II overexpressionL Zhang, M Kim, Y H Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Immunomagnetic purging of Ewing's sarcoma from blood and bone marrow: quantitation by real-time polymerase chain reactionM E Merino, F Navid, B L Christensen, et al.
Cancer Treatment Reports|August 1, 1977
Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agentsD D Von Hoff, M Rozencweig, W T Soper, et al.
Nature Medicine|January 6, 2004
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasisChand Khanna, Xiaolin Wan, Seuli Bose, et al.
The Journal of Biological Chemistry|May 5, 1992
The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cellsC P Minniti, E C Kohn, J H Grubb, et al.
Oncotarget|September 10, 2016
STA-8666, a novel HSP90 inhibitor/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcomaChristine M Heske, Arnulfo Mendoza, Leah D Edessa, et al.
The Journal of Biological Chemistry|August 15, 1988
Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNAL J Helman, T G Ahn, M A Levine, et al.
The Oncologist|February 25, 2012
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003Elizabeth Fox, Shreyaskumar Patel, J Kyle Wathen, et al.
Pageof 22

Showing results (141-150 of 211) with videos related to

Sort By:
Pageof 22
Methods in Enzymology|January 1, 1990
Dispersed salivary gland acinar cell preparations for use in studies of neuroreceptor-coupled secretory eventsB J Baum, I S Ambudkar, J Helman, et al.
Neoplasia (New York, N.Y.)|May 29, 2020
Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomasEmad Darvishi, Katherine Slemmons, Zesheng Wan, et al.
The Journal of Biological Chemistry|May 1, 1999
Diminished G1 checkpoint after gamma-irradiation and altered cell cycle regulation by insulin-like growth factor II overexpressionL Zhang, M Kim, Y H Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Immunomagnetic purging of Ewing's sarcoma from blood and bone marrow: quantitation by real-time polymerase chain reactionM E Merino, F Navid, B L Christensen, et al.
Cancer Treatment Reports|August 1, 1977
Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agentsD D Von Hoff, M Rozencweig, W T Soper, et al.
Nature Medicine|January 6, 2004
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasisChand Khanna, Xiaolin Wan, Seuli Bose, et al.
The Journal of Biological Chemistry|May 5, 1992
The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cellsC P Minniti, E C Kohn, J H Grubb, et al.
Oncotarget|September 10, 2016
STA-8666, a novel HSP90 inhibitor/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcomaChristine M Heske, Arnulfo Mendoza, Leah D Edessa, et al.
The Journal of Biological Chemistry|August 15, 1988
Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNAL J Helman, T G Ahn, M A Levine, et al.
The Oncologist|February 25, 2012
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003Elizabeth Fox, Shreyaskumar Patel, J Kyle Wathen, et al.
Pageof 22